Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: Ex vivo correction of deficient respiratory burst

Gene Therapy

Volumn 4, Issue 6, 1997, Pages 524-532

  Schneider, S D ^a   Rusconi, S ^b   Seger, R A ^a   Hossle, J P ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Adenovirus; Chronic granulomatous disease; Gene therapy; Gene transfer; Macrophages

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME B; NITROBLUE TETRAZOLIUM;

ADENOVIRUS; ADULT; ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CYTOMEGALOVIRUS; ENHANCER REGION; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT GENE; RESPIRATORY BURST; VIRUS RECOMBINANT; X CHROMOSOME LINKAGE;

ADENOVIRIDAE; CYTOMEGALOVIRUS;

EID: 0030877774     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300432     Document Type: Article

References (32)

1. Thrasher AJ, Keep NH, Wientjes F, Segal AW. Chronic granulomatous disease. Biochim Biophys Acta 1994; 1227: 1-24.
2. Fischer A, Segal AW, Seger R, Weening RS. The management of chronic granulomatous disease. Eur J Pediatr 1993; 152: 896-899.
3. Roos D et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87: 1663-1681.
4. Royer-Pokora B et al. Cloning the gene for an inherited human disorder - chronic granulomatous disease - on the basis of its chromosomal location. Nature 1986; 322: 32-38.
5. Seger RA, Ezekowitz RAB. Treatment of chronic granulomatous disease. Immunodeficiency 1994; 5: 113-130.
6. Porter CD et al. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox. Blood 1993; 82: 2196-2202.
7. Kume A, Dinauer MC. Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells. Blood 1994; 84. 3311-3316.
8. Zhen L et al. Gene targeting of X-chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91(phox). Proc Natl Acad Sci USA 1993; 90: 9832-9836.
9. Pollock JD et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9: 202-209.
10. Newburger PE et al. Chronic granulomatous disease: expression of the metabolic defect by in vitro culture of bone marrow progenitors. J Clin Invest 1980; 66: 599-602.
11. Sekhsaria S et al. Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease. Proc Natl Acad Sci USA 1993; 90. 7446-7450.
12. + peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease. Blood 1994; 84: 53-58.
13. Porter CD et al. Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression. Blood 1996; 87: 3722-3730.
14. Malech H. Gene therapy for chronic granulomatous disease. Hum Gen Ther 1995; 6: 1643-1647.
15. Caspar CB, Seger RA, Burger J, Gmür J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulation factor. Blood 1993; 81: 2866-2871.
16. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69: 2257-2263.
17. Haddada H et al. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun 1993; 195: 1174-1183.
18. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982; 31: 543-551.
19. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-72.
20. Hemström C, Nordqvist K, Pettersson U, Virtanen A. Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides. J Virol 1988; 62: 3258-3264.
21. Klebanoff SJ. Phagocytic cells: products of oxygen metabolism. In: Gallin JI, Goldstein IM, Snyderman R (eds). Inflammation: Basic Principles and Clinical Correlates. Raven: New York, 1988.
22. Kreutz M et al. Macrophage heterogeneity and differentiation: defined serum-free culture conditions induce different types of macrophages in vitro. Res Immunol 1992; 143: 107-115.
23. Ramesh N, Shin YK, Lau S, Osborne WRA. High-level expression from cytomegalovirus promoter in macrophage cells. Hum Gen Ther 1995; 6: 1323-1327.
24. Kamani N et al. Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr 1988; 113: 697-700.
25. Bu-Ghanim HN, Segal AW, Keep NH, Casimir CM. Molecular analysis in three cases of X91-variant chronic granulomatous disease. Blood 1995; 86: 3575-3582.
26. De Boer M et al. Large-scale purification and cryopreservation of human monocytes. J Immunol Meth 1981; 43: 225-239.
27. Thrasher AJ et al. Gene transfer to primary chronic granulomatous disease monocytes. Lancet 1995; 346: 92-93.
28. International Chronic Granulomatous Disease Cooperative Study Group (ICCS). A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New Engl J Med 1991; 324: 509-516.
29. Verhoeven AJ et al. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood 1989; 73: 1686-1692.
30. Fallaux FJ et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gen Ther 1996; 7: 215-222.
31. Graham FL, Van der Eb AJ. A new technique for assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
32. Wieland S, Dobbeling U, Rusconi S. Interference and synergism of glucocorticoid receptor and octamer factors. EMBO J 1991; 10: 2513-2521.